康复疫苗公司起诉Moderna,指控其侵犯了mRNA疫苗技术的专利权. CureVac sues Moderna over alleged patent infringement in mRNA vaccine technology.

德国生物技术公司CureVac于4月25日对Moderna提起联邦诉讼,指控该公司侵犯了与COVID-19疫苗中使用的mRNA技术相关的八项专利. German biotech CureVac filed a federal lawsuit against Moderna on April 25, accusing the company of infringing eight patents related to mRNA technology used in COVID-19 vaccines. 康复疫苗声称Moderna仿制了其稳定mRNA的方法,并正在寻求版权使用费. CureVac claims Moderna copied its methods for stabilizing mRNA and is seeking royalties. 这项法律诉讼是继CureVac的母公司BioNTech提出的一起单独诉讼之后, 并增加了主要疫苗制造商之间关于知识产权的持续争议. This legal action follows a separate suit by CureVac’s parent company, BioNTech, and adds to the ongoing disputes among major vaccine manufacturers over intellectual property rights.